Centene (NYSE:CNC) Updates FY 2025 Earnings Guidance

Centene (NYSE:CNC - Get Free Report) issued an update on its FY 2025 earnings guidance on Tuesday morning. The company provided earnings per share (EPS) guidance of 7.250- for the period, compared to the consensus estimate of 7.250. The company issued revenue guidance of -.

Analyst Ratings Changes

A number of equities analysts have commented on CNC shares. Truist Financial decreased their price objective on shares of Centene from $89.00 to $84.00 and set a "buy" rating for the company in a report on Friday, December 13th. Stephens lowered their price objective on shares of Centene from $75.00 to $73.00 and set an "equal weight" rating for the company in a research report on Friday, December 13th. Cantor Fitzgerald reissued an "overweight" rating and issued a $90.00 target price on shares of Centene in a report on Wednesday, December 11th. Sanford C. Bernstein dropped their price target on Centene from $96.00 to $88.00 and set an "outperform" rating on the stock in a research report on Wednesday, October 30th. Finally, Wells Fargo & Company reduced their price objective on Centene from $91.00 to $90.00 and set an "overweight" rating for the company in a research report on Monday, November 4th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and ten have given a buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $81.31.

Centene Price Performance

NYSE:CNC traded up $0.32 during mid-day trading on Friday, reaching $58.95. 3,319,375 shares of the stock were exchanged, compared to its average volume of 4,431,602. Centene has a 1-year low of $55.03 and a 1-year high of $81.42. The company has a current ratio of 1.10, a quick ratio of 1.10 and a debt-to-equity ratio of 0.64. The business has a fifty day moving average price of $61.25 and a 200 day moving average price of $67.00. The firm has a market capitalization of $29.76 billion, a PE ratio of 10.23, a PEG ratio of 0.85 and a beta of 0.45.

Centene (NYSE:CNC - Get Free Report) last released its earnings results on Tuesday, February 4th. The company reported $0.80 EPS for the quarter, beating the consensus estimate of $0.49 by $0.31. The business had revenue of $40.81 billion during the quarter, compared to analyst estimates of $38.78 billion. Centene had a net margin of 1.90% and a return on equity of 13.32%. The business's quarterly revenue was up 3.4% on a year-over-year basis. During the same period in the prior year, the business earned $0.45 earnings per share. Research analysts expect that Centene will post 6.82 earnings per share for the current fiscal year.

Insider Transactions at Centene

In other news, CFO Andrew Lynn Asher acquired 17,200 shares of Centene stock in a transaction on Wednesday, November 13th. The stock was bought at an average cost of $58.14 per share, with a total value of $1,000,008.00. Following the completion of the purchase, the chief financial officer now owns 486,847 shares of the company's stock, valued at $28,305,284.58. This represents a 3.66 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Thomas Greco bought 17,000 shares of the company's stock in a transaction dated Wednesday, December 18th. The stock was purchased at an average cost of $59.75 per share, for a total transaction of $1,015,750.00. Following the completion of the transaction, the director now owns 19,309 shares of the company's stock, valued at $1,153,712.75. This represents a 736.25 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have purchased 40,893 shares of company stock valued at $2,409,962 over the last three months. Company insiders own 0.29% of the company's stock.

Centene Company Profile

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children's health insurance program, foster care, medicare-medicaid plans, long-term services and support.